000			01468nam a2200337Ia 4500
001			EBC3378782
003			MiAaPQ
005			20240121044033.0
006			m o d |
007			cr cn|||||||||
008			110314s2011 dcu sb 000 0 eng d
020			_z9780309212809
035			_a(MiAaPQ)EBC3378782
035			_a(Au-PeEL)EBL3378782
035			_a(CaPaEBR)ebr10478232
035			_a(CaONFJC)MIL313516
035			_a(OCoLC)923283476
040			_aMiAaPQ _cMiAaPQ _dMiAaPQ
050		4	_aRA445 _b.R57 2011
245	0	0	_aRisk-characterization framework for decision-making at the food and drug administration _h[electronic resource] / _cCommittee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
260			_aWashington, DC : _bNational Academies Press, _c2011.
300			_axiv, 192 p.
504			_aIncludes bibliographical references.
533			_aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
610	1	0	_aUnited States. _bFood and Drug Administration _xManagement.
650		0	_aPublic health _zUnited States.
655		4	_aElectronic books.
710	2		_aNational Research Council (U.S.). _bCommittee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
710	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3378782 _zClick to View
999			_c206026 _d206026